Pfizer   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Brooklyn NY United States (1849)

Organization Overview

First Clinical Trial
1984
NCT03164291
First Marketed Drug
1946
streptomycin (kabikinase)
First NDA Approval
1953
viomycin (viocin)
Last Known Activity
2023

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Alpharma Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Altmarc Inc. | Hospira Inc., a Pfizer Company | Hospira, now a wholly owned subsidiary of Pfizer | KING PFIZER | King Pharmaceuticals is now a wholly owned subsidiary of Pfizer | Lederle-Praxis Biologicals | Medical Director; Pfizer, Inc. | Medivation, Inc., a wholly owned subsidiary of Pfizer Inc. | Medivation is now a wholly owned subdiary of Pfizer, Inc. | Parke-Davis, a Division of Pfizer Inc. | PFIPHARMECS | Pfizer | PFIZER | Pfizer, Berlin Germany | Pfizer Clinical Research Unit | PFIZER CONS HLTHCARE | Pfizer CT.gov Call Center | PFIZER GLOBAL | Pfizer Inc. | Pfizer, Inc. | PFIZER INC | Pfizer Incorporated - Ann Arbor | Pfizer Inc., U.S. Pharmaceuticals Group | Pfizer Independent Grants for Learning and Change | PFIZER IRELAND | Pfizer Ireland Pharmaceuticals | PFIZER IRELAND PHARMACEUTICALS | PFIZER LABS | PFIZER PHARMS | PF PRISM CV | ROERIG | The BMS/Pfizer Japan Thrombosis Investigator Initiated Research Program | Wyeth is now a wholly owned subsidiary of Pfizer